Clinical

This channel newsfeed includes clinical content on treating patients or the clinical implications in a variety of cardiac subspecialties and disease states. The channel includes news on cardiac surgery, interventional cardiology, heart failure, electrophysiology, hypertension, structural heart disease, use of pharmaceuticals, and COVID-19.

Chemical alterations in the brain hint at whether loss of smell will return post-COVID
Researchers have identified what they believe could serve as imaging biomarkers that predict recovery from anosmia after contracting the virus.
Early outcomes with Myval TAVR valve comparable to popular devices from Medtronic, Edwards
Meril Life Sciences has been manufacturing its Myval heart valves for years. The devices are approved and available in both India and Europe, but they have not been approved by the FDA.
Surgeons make history again with world’s first robotic implant of Abbott heart device
The historic LVAD implant was performed on a 35-year-old patient with advanced heart failure. His symptoms included kidney and lung deterioration.
Q&A: Society of Thoracic Surgeons president previews the trends and technologies of STS 2025
It looked like the wildfires in Los Angeles could force STS to cancel its annual meeting, but the group worked with city officials and was able to carry on as planned. STS President Jennifer C. Romano, MD, MS, discussed that difficult decision and previewed the three-day event in a new interview.
Key details associated with the treatment of COVID-induced arrhythmias
Rakesh Gopinathannair, MD, lead author of a recent American Heart Association scientific statement on cardiac arrhythmias associated with COVID-19, reviewed the latest science associated with this important topic.

First patient treated with CSI’s new peripheral support catheter

A vascular surgeon in Nashville performed the procedure, praising the device's "balance of support and flexibility."

TAVR safe and effective for patients with cirrhosis

Patients with cirrhosis of the liver often undergo TAVR at a younger age, but the outcomes remain strong.

American Heart Association, FDA comment on continued popularity of e-cigarettes

According to a new analysis, 27.6% of high school students say they use e-cigarettes daily.

New battery-powered device diagnoses heart attacks in just minutes

The portable sensor, developed by specialists at the University of Notre Dame and University of Florida, targets the patient's microRNA.

How family can help patients win the battle against CVD

The two-year analysis included patients with a confirmed diagnosis of coronary heart disease.

Remote PA pressure monitoring pays off when treating HF patients

The study, published in Current Problems in Cardiology, included both a systematic review and a meta-analysis.

Panic buttons for hospital workers — passing COVID fad or new but permanent normal?

Faced with sharply spiking assault rates against nurses and other frontline healthcare workers, one U.S. medical center is equipping hundreds of its people with wearables that can summon security at the click of a button.

How ITA harvesting techniques during CABG affect long-term outcomes

The new analysis, published in JAMA Cardiology, included data from 28 different facilities.

Clinical

Chemical alterations in the brain hint at whether loss of smell will return post-COVID

Early outcomes with Myval TAVR valve comparable to popular devices from Medtronic, Edwards

Surgeons make history again with world’s first robotic implant of Abbott heart device

Q&A: Society of Thoracic Surgeons president previews the trends and technologies of STS 2025

Key details associated with the treatment of COVID-induced arrhythmias